series-c-plus
Stage
2
Investors
About
Healios Ltd develops regenerative medicine therapies using iPSC-based pharmaceuticals and stem cell treatments targeting diseases including retinal disorders, stroke, and acute respiratory distress syndrome.
Explore Healios Ltd's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.